Further mechanisms of tigecycline include inhibition of the Wnt/β-catenin pathway in CRC and cervical squamous carcinoma models, as well as suppression of the STAT3 signaling pathway, which regulates CRC proliferation and metastasis. The gene discussed is STAT3; the disease is colorectal carcinoma.